Human Mitochondrial Leucyl-tRNA Synthetase Corrects Mitochondrial Dysfunctions Due to the tRNA^Leu(UUR) A3243G Mutation, Associated with Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Symptoms and Diabetes

REFERENCES

• Börner, G. V., M. Zeviani, V. Tiranti, F. Carrara, S. Hoffmann, K. D. Gerbitz, H. Lochmüller, D. Pongratz, T. Klopstock, A. Melberg, E. Holme, and S. Pääbo. 2000. Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. Hum. Mol. Genet. 9:467–475.
   PubMedGoogle Scholar
• Brandon, M. C., M. T. Lott, K. C. Nguyen, S. Spolim, S. B. Navathe, P. Baldi, and D. C. Wallace. 2005. MITOMAP: a human mitochondrial genome database—2004 update. Nucleic Acids Res. 33:D611–D613.
   PubMed Web of Science ®Google Scholar
• Bullard, J. M., Y. C. Cai, and L. L. Spremulli. 2000. Expression and characterization of the human mitochondrial leucyl-tRNA synthetase. Biochim. Biophys. Acta 1490:245–258.
   PubMedGoogle Scholar
• Chomyn, A. 1996. In vivo labeling and analysis of human mitochondrial translation products. Methods Enzymol. 264:197–211.
   PubMedGoogle Scholar
• Chomyn, A., J. A. Enriquez, V. Micol, P. Fernandez-Silva, and G. Attardi. 2000. The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. J. Biol. Chem. 275:19198–19209.
   PubMed Web of Science ®Google Scholar
• De Luca, C., C. Besagni, L. Frontali, M. Bolotin-Fukuhara, and S. Francisci. 2006. Mutations in yeast mt tRNAs: specific and general suppression by nuclear encoded tRNA interactors. Gene 377:169–176.
   PubMedGoogle Scholar
• Deng, J. H., Y. Li, J. S. Park, J. Wu, P. Hu, J. Lechleiter, and Y. Bai. 2006. Nuclear suppression of mitochondrial defects in cells without the ND6 subunit. Mol. Cell. Biol. 26:1077–1086.
   PubMedGoogle Scholar
• Dunbar, D. R., P. A. Moonie, M. Zeviani, and I. J. Holt. 1996. Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids. Hum. Mol. Genet. 5:123–129.
   PubMed Web of Science ®Google Scholar
• El Meziane, A., S. K. Lehtinen, N. Hance, L. G. Nijtmans, D. Dunbar, I. J. Holt, and H. T. Jacobs. 1998. A tRNA suppressor mutation in human mitochondria. Nat. Genet. 18:350–353.
   PubMedGoogle Scholar
• Enríquez, J. A., and G. Attardi. 1996. Analysis of aminoacylation of human mitochondrial tRNAs. Methods Enzymol. 264:183–196.
   PubMedGoogle Scholar
• Feuermann, M., S. Francisci, T. Rinaldi, C. De Luca, H. Rohou, L. Frontali, and M. Bolotin-Fukuhara. 2003. The yeast counterparts of human ‘MELAS’ mutations cause mitochondrial dysfunction that can be rescued by overexpression of the mitochondrial translation factor EF-Tu. EMBO Rep. 4:53–58.
   PubMed Web of Science ®Google Scholar
• Flierl, A., H. Reichmann, and P. Seibel. 1997. Pathophysiology of the MELAS 3243 transition mutation. J. Biol. Chem. 272:27189–27196.
   PubMed Web of Science ®Google Scholar
• Florentz, C., B. Sohm, P. Tryoen-Toth, J. Putz, and M. Sissler. 2003. Human mitochondrial tRNAs in health and disease. Cell. Mol. Life Sci. 60:1356–1375.
   PubMed Web of Science ®Google Scholar
• Goto, Y., I. Nonaka, and S. Horai. 1990. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651–653.
   PubMed Web of Science ®Google Scholar
• Guan, M. X., N. Fischel-Ghodsian, and G. Attardi. 1996. Biochemical evidence for nuclear gene involvement in phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation. Hum. Mol. Genet. 5:963–971.
   PubMed Web of Science ®Google Scholar
• Guan, M. X., J. A. Enriquez, N. Fischel-Ghodsian, R. S. Puranam, C. P. Lin, M. A. Maw, and G. Attardi. 1998. The deafness-associated mitochondrial DNA mutation at position 7445, which affects tRNASer(UCN) precursor processing, has long-range effects on NADH dehydrogenase subunit ND6 gene expression. Mol. Cell. Biol. 18:5868–5879.
   PubMedGoogle Scholar
• Guan, M. X., Q. Yan, X. Li, Y. Bykhovskaya, J. Gallo-Teran, P. Hajek, N. Umeda, H. Zhao, G. Garrido, E. Mengesha, T. Suzuki, I. del Castillo, J. L. Peters, R. Li, Y. Qian, X. Wang, E. Ballana, M. Shohat, J. Lu, X. Estivill, K. Watanabe, and N. Fischel-Ghodsian. 2006. Mutation in TRMU related to transfer RNA modification modulates the phenotypic expression of the deafness-associated mitochondrial 12S ribosomal RNA mutations. Am. J. Hum. Genet. 79:291–302.
   PubMed Web of Science ®Google Scholar
• Hartl, F. U., and W. Neupert. 1990. Protein sorting to mitochondria: evolutionary conservations of folding and assembly. Science 247:930–938.
   PubMed Web of Science ®Google Scholar
• Helm, M., C. Florentz, A. Chomyn, and G. Attardi. 1999. Search for differences in post-transcriptional modification patterns of mitochondrial DNA-encoded wild-type and mutant human tRNALys and tRNALeu(UUR). Nucleic Acids Res. 27:756–763.
   PubMed Web of Science ®Google Scholar
• Jacobs, H. 2003. Disorders of mitochondrial protein synthesis. Hum. Mol. Genet. 12:R293–R301.
   PubMedGoogle Scholar
• Janssen, G. M., P. J. Hensbergen, F. J. van Bussel, C. I. Balog, J. A. Maassen, A. M. Deelder, and A. K. Raap. 2007. The A3243G tRNALeu(UUR) mutation induces mitochondrial dysfunction and variable disease expression without dominant negative acting translational defects in complex IV subunits at UUR codons. Hum. Mol. Genet. 16:2472–2481.
   PubMedGoogle Scholar
• Kaufmann, P., Y. Koga, S. Shanske, M. Hirano, S. DiMauro, M. P. King, and E. A. Schon. 1996. Mitochondrial DNA and RNA processing in MELAS. Ann. Neurol. 40:172–180.
   PubMedGoogle Scholar
• King, M. P., and G. Attardi. 1989. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246:500–503.
   PubMed Web of Science ®Google Scholar
• King, M. P., Y. Koga, M. Davidson, and E. A. Schon. 1992. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNALeu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol. Cell. Biol. 12:480–490.
   PubMed Web of Science ®Google Scholar
• King, M. P., and G. Attardi. 1993. Post-transcriptional regulation of the steady-state levels of mitochondrial tRNAs in HeLa cells. J. Biol. Chem. 268:10228–10237.
   PubMed Web of Science ®Google Scholar
• Kirino, Y., T. Yasukawa, S. Ohta, S. Akira, K. Ishihara, K. Watanabe, and T. Suzuki. 2004. Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease Proc. Natl. Acad. Sci. U. S. A. 101:15070–15075.
   PubMed Web of Science ®Google Scholar
• Kiss, H., D. Kedra, Y. Yang, M. Kost-Alimova, C. Kiss, K. P. O'Brian, I. Fransson, G. Klein, S. Imreh, and J. P. Dumanski. 1999. A novel gene containing LIM domains (LIMD1) is located within the common eliminated region 1 (C3CER1) in 3p21.3. Hum. Genet. 105:552–559.
   PubMedGoogle Scholar
• Larsson, N. G., and D. A. Clayton. 1995. Molecular genetic aspects of human mitochondrial disorders. Annu. Rev. Genet. 29:151–178.
   PubMed Web of Science ®Google Scholar
• Li, X., and M.-X. Guan. 2002. A human mitochondrial GTP binding protein related to tRNA modification may modulate phenotypic expression of the deafness-associated mitochondrial 12S rRNA mutation. Mol. Cell. Biol. 22:7701–7711.
   PubMedGoogle Scholar
• Li, X., R. Li, X. Lin, and M.-X. Guan. 2002. Isolation and characterization of the putative nuclear modifier gene MTO1 involved in the pathogenesis of deafness-associated mitochondrial 12 S rRNA A1555G mutation. J. Biol. Chem. 277:27256–27264.
   PubMed Web of Science ®Google Scholar
• Li, X., N. Fischel-Ghodsian, F. Schwartz, Q. Yan, R. A. Friedman, and M. X. Guan. 2004. Biochemical characterization of the mitochondrial tRNASer(UCN) T7511C mutation associated with nonsyndromic deafness. Nucleic Acids Res. 32:867–877.
   PubMed Web of Science ®Google Scholar
• Ling, J., H. Roy, D. Qin, M. A. Rubio, J. D. Alfonzo, K. Fredrick, and M. Ibba. 2007. Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome. Proc. Natl. Acad. Sci. U. S. A. 104:15299–15304.
   PubMedGoogle Scholar
• Liu, Y., R. Li, Z. Li, X. J. Wang, L. Yang, S. Wang, and M. X. Guan. 2009. Mitochondrial transfer RNAMet 4435A>G mutation is associated with maternally inherited hypertension in a Chinese pedigree. Hypertension 53:1083–1090.
   PubMed Web of Science ®Google Scholar
• Lu, J., D. Wang, R. Li, W. Li, J. Ji, J. Zhao, W. Ye, L. Yang, Y. Qian, Y. Zhu, and M. X. Guan. 2006. Maternally transmitted diabetes mellitus associated with the mitochondrial tRNALeu(UUR) A3243G mutation in a four-generation Han Chinese family. Biochem. Biophy. Res. Commun. 348:115–119.
   PubMed Web of Science ®Google Scholar
• Maassen, J. A., L. M.'t Hart, E. van Essen, R. J. Heine, G. Nijpels, R. S. Jahangir Tafrechi, A. K. Raap, G. M. C. Janssen, and H. H. Lemkes. 2004. Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 53 (Suppl. 1):S103–S109.
   PubMed Web of Science ®Google Scholar
• Magalhaes, P. J., A. L. Andreu, and E. A. Schon. 1998. Evidence for the presence of 5S rRNA in mammalian mitochondria. Mol. Biol. Cell 9:2375–2382.
   PubMed Web of Science ®Google Scholar
• Ohkubo, K., A. Yamano, M. Nagashima, Y. Mori, K. Anzai, Y. Akehi, R. Nomiyama, T. Asano, A. Urae, and J. Ono. 2001. Mitochondrial gene mutations in the tRNALeu(UUR) region and diabetes: prevalence and clinical phenotypes in Japan. Clin. Chem. 47:1641–1648.
   PubMed Web of Science ®Google Scholar
• Park, H., E. Davidson, and M. P. King. 2003. The pathogenic A3243G mutation in human mitochondrial tRNALeu(UUR) decreases the efficiency of aminoacylation. Biochemistry 42:958–964.
   PubMed Web of Science ®Google Scholar
• Park, H., E. Davidson, and M. P. King. 2008. Overexpressed mitochondrial leucyl-tRNA synthetase suppresses the A3243G mutation in the mitochondrial tRNALeu(UUR) gene. RNA 14:2407–2416.
   PubMedGoogle Scholar
• Rorbach, J., A. A. Yusoff, H. Tuppen, D. P. Abg-Kamaludin, Z. M. Chrzanowska-Lightowlers, R. W. Taylor, D. M. Turnbull, R. McFarland, and R. N. Lightowlers. 2008. Overexpression of human mitochondrial valyl tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying the pathogenic C25U mutation. Nucleic Acids Res. 36:3065–3074.
   PubMed Web of Science ®Google Scholar
• Rossmanith, W., and R. Karwan. 1998. Impairment of tRNA processing by point mutations in mitochondrial tRNALeu(UUR) associated with mitochondrial diseases. FEBS Lett. 433:269–274.
   PubMed Web of Science ®Google Scholar
• Sasarman, F., H. Antonicka, and E. A. Shoubridge. 2008. The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2. Hum. Mol. Genet. 17:3697–3707.
   PubMedGoogle Scholar
• Sohm, B., M. Sissler, H. Park, M. P. King, and C. Florentz. 2004. Recognition of human mitochondrial tRNALeu(UUR) by its cognate leucyl-tRNA synthetase. J. Mol. Biol. 339:17–29.
   PubMedGoogle Scholar
• Srivastava, S., F. Diaz, L. Iommarini, K. Aure, A. Lombes, and C. T. Moraes. 2009. PGC-1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Hum. Mol. Genet. 18:1805–1812.
   PubMed Web of Science ®Google Scholar
• van den Ouweland, J. M. W., H. H. P. J. Lemkes, W. Ruitenbeek, L. A. Sandkuijl, M. F. de Vijlder, P. A. A. Struijvenberg, J. J. P. van de Kamp, and J. A. Maassen. 1992. Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat. Genet. 1:368–371.
   PubMed Web of Science ®Google Scholar
• Varshney, U., C. P. Lee, and U. L. RajBhandary. 1991. Direct analysis of aminoacylation levels of tRNAs in vivo. Application to studying recognition of Escherichia coli initiator tRNA mutants by glutaminyl-tRNA synthetase. J. Biol. Chem. 1266:24712–24718.
   Google Scholar
• Wallace, D. C. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39:359–407.
   PubMed Web of Science ®Google Scholar
• Wang, X., J. Lu, Y. Zhu, A. Yang, L. Yang, R. Li, B. Chen, Y. Qian, X. Tang, J. Wang, X. Zhang, and M. X. Guan. 2008. Mitochondrial tRNAThr G15927A mutation may modulate the phenotypic manifestation of ototoxic 12S rRNA A1555G mutation in four Chinese families. Pharmacogenet. Genom. 18:1059–1070.
   PubMed Web of Science ®Google Scholar
• Yan, Q., X. Li, G. Faye, and M. X. Guan. 2005. Mutations in MTO2 related to tRNA modification impair mitochondrial gene expression and protein synthesis in the presence of a paromomycin resistance mutation in mitochondrial 15 S rRNA. J. Biol. Chem. 280:29151–29157.
   PubMed Web of Science ®Google Scholar
• Yasukawa, T., T. Suzuki, T. Suzuki, T. Ueda, S. Ohta, and K. Watanabe. 2000. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAsLeu(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J. Biol. Chem. 275:4251–4257.
   PubMed Web of Science ®Google Scholar
• Yoneda, M., A. Chomyn, A. Martinuzzi, O. Hurko, and G. Attardi. 1992. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyelopathy. Proc. Natl. Acad. Sci. U. S. A. 89:11164–11168.
   PubMed Web of Science ®Google Scholar